5 completed, 1 withdrawn. 4 Phase 2, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Withdrawn 1 |
| Not applicable | 2 | Completed 2 |
Follow PAZ320: new trials by email Literature Review of PAZ320 trials Research Report on PAZ320
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes BTI320, Placebo - Type2 Diabetes Mellitus | Phase 2 | Completed | Boston Therapeutics | 66 | 2018-09-19 | 2020-09-25 |
| BTI320 (SUGARDOWN®) on Post-Prandial Hyperglycaemia in Subjects With Pre-Diabetes BTI320, BTI320 matching placebo - Pre-Diabetes | Phase 2 | Completed | Chinese University of Hong Kong | 60 | 2015-03-30 | 2017-04-25 |
| Determination of the GI and II Values of Soft Drink and Soft Drink With Sugardown™ Sugardown™, Soft drink - Postprandial Hyperglycemia | Not applicable | Completed | Boston Therapeutics | 10 | 2014-11-01 | 2017-12-15 |
| The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients PAZ320, Placebo - Type II Diabetes | Phase 2 | Withdrawn | Boston Therapeutics | 2012-09-01 | 2020-09-29 | |
| Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 Diabetes PAZ320 - Type 2 Diabetes Treated With Insulin | Phase 2 | Completed | Boston Therapeutics | 24 | 2011-03-01 | 2014-02-13 |
| Determination of the PPG and Insulin Responses of Rice Alone and Rice Consumed With Sugardown™ Rice, Sugardown™ - Postprandial Hyperglycemia | Not applicable | Completed | Boston Therapeutics | 10 | 2011-03-01 | 2017-12-18 |
Hyperglycemia (2) · Insulin Resistance (2) · Diabetes Mellitus, Type 2 (1) · Glucose Intolerance (1)
Boston Therapeutics (5) · Chinese University of Hong Kong (1)
United States (2) · France (1) · Hong Kong (1)
Andrea OY Luk, MBBS (1) · Jennie Brand-Miller (1) · Jennie Brand-Miller, Prof. (1) · Laura E Trask, MD (1)